Results 21 to 30 of about 10,951,042 (362)

Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension

Pulmonary Circulation, 2022
Patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (PH) are at increased risk when undergoing anesthesia and major surgery. Data on outcomes for elective orthopedic surgery in patients with PH are limited.
Mikaela Wardle, Amanda Nair, Sarah Saunders, Iain Armstrong, Athanasios Charalampopoulos, Charlie Elliot, Abdul Hameed, Neil Hamilton, John Harrington, Carol Keen, Robert Lewis, Ian Sabroe, A. A. Roger Thompson, Robert M. Kerry, Robin Condliffe, David G. Kiely   +15 more
doaj   +1 more source

Association of clonal hematopoiesis with chronic obstructive pulmonary disease

Blood, 2021
Clonal hematopoiesis of indeterminate potential (CHIP) is an age-related phenomenon that induces inflammation. Since CHIP is a risk factor for cardiovascular disease, Miller and colleagues investigated the association between CHIP and chronic obstructive
P. Miller, D. Qiao, J. Rojas-Quintero, M. Honigberg, A. Sperling, C. Gibson, A. Bick, A. Niroula, M. McConkey, Brittany Sandoval, Brian C Miller, Weiwei Shi, Kaushik Viswanathan, Matthew J. Leventhal, L. Werner, M. Moll, B. Cade, R. Barr, A. Correa, L. Cupples, Sina A. Gharib, D. Jain, S. Gogarten, L. Lange, Stephanie A. London, A. Manichaikul, G. O'Connor, E. Oelsner, S. Redline, S. Rich, J. Rotter, V. Ramachandran, B. Yu, L. Sholl, D. Neuberg, S. Jaiswal, B. Levy, C. Owen, P. Natarajan, E. Silverman, Peter van Galen, Y. Tesfaigzi, M. Cho, B. Ebert   +43 more
semanticscholar   +1 more source

COgnitive-Pulmonary Disease [PDF]

BioMed Research International, 2014
Over the past few decades, chronic obstructive lung disease (COPD) has been considered a disease of the lungs, often caused by smoking. Nowadays, COPD is regarded as a systemic disease. Both physical effects and effects on brains, including impaired psychological and cognitive functioning, have been demonstrated.
Rudolf W. H. M. Ponds, Fiona A H M Cleutjens, Jeanette B. Dijkstra, Daisy J.A. Janssen, Emiel F.M. Wouters   +4 more
openaire   +4 more sources

Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers

Journal of Thoracic Disease, 2021
Medication non-adherence to asthma and chronic obstructive pulmonary disease therapy poses a significant burden for patients and societies. Non-adherence encompasses poor initiation, implementation (including poor inhalation technique) and non ...
Evalyne M Jansen, S. J. van de Hei, B. Dierick, H. Kerstjens, J. Kocks, Job F. M. van Boven   +5 more
semanticscholar   +1 more source

A 73‐year‐old man with loss of consciousness during treatment for miliary tuberculosis

Respirology Case Reports, 2022
Key message Miliary tuberculosis is often associated with cerebral tuberculoma, which can manifest during treatment. We present images of a patient with cerebral tuberculoma detected due to emerging neurological symptoms during treatment of miliary ...
Masahiro Ohgiya, Yuka Sasaki, Akira Yamane, Sumie Nakamura, Hirotoshi Matsui   +4 more
doaj   +1 more source

Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary.

Clinical Infectious Diseases, 2020
Nontuberculous mycobacteria (NTM) represent over 190 species and subspecies, some of which can produce disease in humans of all ages and can affect both pulmonary and extrapulmonary sites.
C. Daley, J. Iaccarino, C. Lange, E. Cambau, R. Wallace, C. Andrejak, E. Böttger, J. Brożek, D. Griffith, L. Guglielmetti, G. Huitt, Shandra L. Knight, P. Leitman, T. Marras, K. Olivier, M. Santin, J. Stout, E. Tortoli, J. van Ingen, D. Wagner, K. Winthrop   +20 more
semanticscholar   +1 more source

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?

European Respiratory Review, 2020
Despite the advent of new therapies and improved outcomes in patients with pulmonary arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis remains unchanged.
Robert A. Lewis, Charlotte Durrington, Robin Condliffe, David G. Kiely   +3 more
doaj   +1 more source

Implementing integrated care guidelines in asthma and COPD: It ain't easy!

Heliyon, 2023
Objective: To evaluate the implementation of a guideline-based, integrated, standardised, personal approach in patients with Chronic Obstructive Pulmonary Disease (COPD) or Asthma in a real-life situation.
Jan A. Witte, Erwin Birnie, Gert-Jan Braunstahl, Edmée van den Akker, Walter J.M. van Litsenburg, Niels H. Chavannes, Maureen P.M.H. Rutten - van Mölken, Johannes C.C.M. In ’t Veen   +7 more
doaj   +1 more source

Association between weight loss and mortality in idiopathic pulmonary fibrosis

Respiratory Research, 2022
Rationale Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease that has no cure. Many current research efforts center on diagnostic and therapeutic modalities for IPF while other risk factors affecting disease ...
Aleksandr Kalininskiy, Ashley Rose Rackow, David Nagel, Daniel Croft, Heather McGrane-Minton, Robert Matthew Kottmann   +5 more
doaj   +1 more source

Pulmonary Diseases and Corticosteroids [PDF]

The Indian Journal of Pediatrics, 2008
Steroids (corticosteroids) are anti-inflammatory drugs. Corticosteroids are used in many pulmonary conditions. Corticosteroids have a proven beneficial role in asthma, croup (Laryngotracheobronchitis), decreasing the risk and severity of respiratory distress syndrome (RDS), allergic bronchopulmonary aspergillosis, interstitial lung disease, hemangioma ...
Gulshan Rai Sethi, Kamal Kumar Singhal
openaire   +3 more sources